Trial intelligence / Profile preview

EVP-6124 scopolamine challenge crossover study in healthy elderly subjects

NL-OMON41062Active, not recruiting

Sponsor
FORUM Pharmaceuticals
Start
Nov 2014
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of encenicline, sponsored by FORUM Pharmaceuticals. Started Nov 2014; status: active, not recruiting.

02

Drugs

encenicline

Beyond the preview

Go deeper on NL-OMON41062.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON41062.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call